Streetbeat News

Products Services

PLUG

Plug Power has secured contracts to supply cryogenic equipment to a multinational industrial gas company and a statewide electric utility company, with an additional agreement in the final stages with another leading industrial gas company. The partnership includes supplying five cryogenic trailers for the Canadian market, expected to be delivered in early 2025. This equipment is essential for transporting cryogenic industrial gases such as nitrogen, argon, and oxygen.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:50 am

ORGN

Origin Materials has partnered with IMDvista to create the world's first commercial-scale PET cap and closure manufacturing system. This innovation aims to enhance recycling circularity by enabling mono-material containers, lighter packaging, and improved product shelf life.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:48 am

ORGO

Organogenesis shares surged following the announcement that its Phase 3 trial for ReNu met its primary safety and efficacy endpoint.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:45 am

THTX

Theratechnologies announced it will present long-term efficacy, safety, and pharmacokinetic data on TH1902 (Sudocetaxel Zendusortide), its lead investigational drug for treating solid tumors, at the American Society of Clinical Oncology.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:39 am

TSLA

Tesla Inc (NASDAQ:TSLA) is rumored to introduce a new voice assistant and Amazon Music playback support in its Spring software update, according to Tesla hacker Green. The update, teased by Tesla in April, will also feature immersive full-screen vehicle controls, expandable autopilot driving visualizations, and enhanced trunk accessibility. Additionally, Tesla plans to remove the occupancy sensor in the driver's seat, relying instead on the interior cabin camera.

Portfolio Pulse from Anan Ashraf

May 02, 2024 | 11:39 am

PTN

The FDA has approved Palatin Technologies' IND application for a Phase 2 study of Bremelanotide in combination with Tirzepatide for obesity treatment. The study is set to begin by mid-2024, with results expected by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:38 am

CNTX

Context Therapeutics received FDA clearance for its IND application, allowing it to proceed with a Phase 1 clinical trial of CTIM-76. This marks a significant step forward in the company's development pipeline, potentially impacting its stock as investors react to the progress in its clinical trial endeavors.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:34 am

RDCM

U.S. Operator has chosen RADCOM Ltd. (RDCM) to provide a SaaS service assurance solution hosted on Amazon Web Services (AWS). This partnership highlights RADCOM's capabilities in delivering cloud-native service assurance solutions and strengthens its position in the SaaS market.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:31 am

R

U.K.-based footwear brand FitFlop has chosen Ryder, a leader in supply chain, dedicated transportation, and fleet management solutions, as its U.S. supply chain and logistics provider. This partnership aims to enhance FitFlop's distribution capabilities in the U.S. market.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:22 am

WBA

Walgreens and Boehringer Ingelheim have partnered to enhance diversity in clinical trials, focusing on obesity, overweight, and type 2 diabetes by using select Walgreens pharmacies as trial sites.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 11:17 am